Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,072
Closed -$84.1K 434
2025
Q4
$84.1K Buy
2,072
+1,975
+2,036% +$85.9K ﹤0.01% 1803
2025
Q3
$4.56K Buy
97
+96
+9,600% +$4.98K ﹤0.01% 2191
2025
Q2
$52 Hold
1
﹤0.01% 1963
2025
Q1
$60 Hold
1
﹤0.01% 1993
2024
Q4
$68 Sell
1
-237
-100% -$16.5K ﹤0.01% 1634
2024
Q3
$17.1K Sell
238
-295
-55% -$20.8K ﹤0.01% 1516
2024
Q2
$36.9K Sell
533
-2,568
-83% -$187K 0.01% 1175
2024
Q1
$248K Buy
+3,101
New +$276K 0.04% 582

Other funds holding CNMD

AlphaQuest's CNMD Position: Q1 2026 in Review

AlphaQuest sold out of CONMED (CNMD) in Q1 2026, closing a stake of 2,072 shares — an estimated $84.1K sold.

AlphaQuest first reported a position in CNMD in Q1 2024 and held it in 8 quarters. The position peaked at $248K in Q1 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • AlphaQuest reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 2,072 CONMED shares in Q1 2026, an estimated $84.1K.
  • AlphaQuest first reported a position in CONMED in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's CONMED position peaked at $248K in Q1 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.